Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Partnering Agreement with INSOMNIS Media Limited

28 Oct 2015 07:00

RNS Number : 6403D
Phorm Corporation Limited
28 October 2015
 

28 October 2015

 

Phorm Corporation Limited

("Phorm" or the "Company")

 

Partnering Agreement with INSOMNIS Media Limited

Channel sales partnership entered into with INSOMNIS to expand its technology footprint and improve global advertising campaign performance

Phorm (AIM:PHRM), a leading advertising-technology company and first party data platform provider, is pleased to announce that, further to its interim results released on 30 September 2015, it has formally entered into a channel sales partnership with INSOMNIS Media Limited ("INSOMNIS").

 

INSOMNIS, a digital media business specialising in the delivery of behavioral targeting and performance campaign solutions for its clients, will seek to leverage Phorm's proprietary technology and machine learning algorithms to identify users through a first party approach leading to more effective targeting, personalised messaging and efficient overall campaign delivery.

 

Phorm's first party data platform technology sits above digital properties, off network supply sources and real-time bidding platforms, where it synthesises user data, develops profiles and addresses users personalised with content or advertising messages at the point where the user is engaging client's websites. Brands, publishers and programmatic sources can clearly benefit when known users are able to engage with personalised content and it is therefore more effective and efficient for both the inventory and demand sides of our clients' businesses. The Company's technology provides unparalleled insight and a holistic view into digital advertising dynamics such that agencies and advertisers can achieve optimal inventory control and return on their investment.

 

 

CEO of INSOMNIS, Mr Mike Moran, commented:

 

"Brand managers have become particularly focused on whether they are messaging to their desired user base, which is often difficult to prove in the context of online advertising. Issues like privacy and viewability are becoming increasingly important to advertisers when they choose their partner for their display targeting and retargeting activity.

"We have every confidence in Phorm's tech platform and our partnership with Phorm will enable us to present our campaign metrics to clients, knowing that we have utilised first party data to deliver the brand's specific user base most efficiently. This is precisely the area where the online advertising industry needed to evolve."

 

Phorm's CEO, Timothy Smith, added:

 

"Mike Moran, Paul Grundy and their colleagues at INSOMNIS possess a wealth of ad industry expertise and relationships. Together, we've already helped a brand and publishing client in the U.K. achieve a successful campaign, which has provided validation that our initial partnership is already yielding results. We now look forward to extending this initial track record of success to the U.S. market."

 

 

-Ends-

 

 

 

For Phorm information please contact:

Phorm Corporation Limited

Timothy Smith (Chief Executive Officer) +44 (0)20 3397 6001

 

Mirabaud Securities LLP (Broker) +44 (0)20 7321 2508

Jason Woollard 

Peter Krens

 

Strand Hanson Limited (Nominated Adviser) +44 (0)20 7409 3494

James Harris Matthew Chandler James Dance

 

About Phorm

 

Phorm (PHRM:AIM) is a leading advertising-technology and first party data platform provider that enables brands and publishers to address online users with personalised content and advertising. Phorm's innovative platform delivers a more interesting online experience for the user and addressable campaign results for marketers. For more information, please visit: www.phorm.com

 

For Insomnis Media information please contact:

 

BrandMee

Marie Ellis +44 (0)7454 222611

 

About Insomnis Media

 

INSOMNIS is a digital media business specialising in behavioural targeting and driving campaign performance.

 

We use market-leading technology, which learns about our advertiser's audience, both prior to and during a campaign, which allows us to continuously improve performance by modifying CPCs/CPMs to maximise efficiency and programmatic/RTB win rates.

 

Visit us at www.insomnis-media.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRALDLLLEBFXFBQ
Date   Source Headline
14th Apr 201610:00 amRNSUpdate and Resignation of Nominated Adviser
16th Mar 201612:37 pmRNSIssue of US$500,000 of Convertible Loan Notes
16th Mar 20167:00 amRNSIssue of US$500,000 of Convertible Loan Notes
25th Feb 20168:02 amRNSFunding Update and Statement re Suspension
25th Feb 20167:55 amRNSSuspension - Phorm Corporation Limited
4th Feb 20166:05 pmRNSFunding Update
1st Feb 20163:49 pmRNSSubscription Update, New Subscription & Loan
21st Jan 20167:00 amRNSPhorm Awarded TRUSTe Certified Privacy Seal
18th Jan 20167:00 amRNSSubscription & Operational Update
5th Jan 20162:00 pmRNSTR-1: Notification of major interest in shares
23rd Dec 20151:00 pmRNSRevised Non-Executive Director Compensation
22nd Dec 20157:00 amRNSDirectorate Change
7th Dec 20157:00 amRNSRepricing of Options
3rd Dec 201511:00 amRNSPhorm Enables Hover Rate with Insomnis Media
1st Dec 20157:00 amRNSNew Share Option Plan and Grant of Options
18th Nov 20157:00 amRNSTR-1: Notifications of Major Interests in Shares
28th Oct 20157:00 amRNSPartnering Agreement with INSOMNIS Media Limited
20th Oct 20157:00 amRNSAgreement with Causemo, Inc.
13th Oct 20157:00 amRNSPhorm Hires Chief Revenue Officer
9th Oct 20157:00 amRNSAgreement with Boston Globe Media Group
30th Sep 20151:33 pmRNSInterim Results
28th Aug 20152:38 pmRNSResult of AGM
10th Aug 20157:00 amRNSNotice of Annual General Meeting
7th Aug 20157:48 amRNSEquity fundraising of approximately £3.2 million
29th Jul 20157:02 amRNSUpdate re Board Changes
28th Jul 20157:00 amRNSLoan Agreement & Convertible Loan Note Extension
15th Jul 201511:21 amRNSBoard and Management Changes
3rd Jul 20157:00 amRNSOperational Update
2nd Jul 20157:16 amRNSDirectorate Change
30th Jun 20157:00 amRNSAnnual Financial Report
8th May 20154:00 pmRNSTR-1: Notification of major interest in shares
22nd Apr 20157:00 amRNSEquity Fundraising of £6.0 million Gross
21st Apr 20154:22 pmRNSOperational Update
16th Mar 20153:45 pmRNSDirectorate Change
25th Feb 20157:02 amRNSBoard Changes
19th Jan 20157:00 amRNSEquity fundraising of approximately £6.25 million
16th Jan 20157:21 amRNSOperational Update
8th Dec 20147:00 amRNSEquity Fundraising
28th Oct 20147:00 amRNSTR-1: Notification of major interest in shares
8th Oct 20147:00 amRNSEquity fundraising of £4.47 million
6th Oct 20147:00 amRNSOperational Update
22nd Aug 20147:05 amRNSSubscription To Raise £2.4 million
22nd Aug 20147:00 amRNSInterim Results
24th Jul 20142:31 pmRNSResult of Annual General Meeting
27th Jun 20147:30 amRNSGlobal Operations Update
27th Jun 20147:05 amRNSNotice of Annual General Meeting and Board Changes
27th Jun 20147:00 amRNSFinal Results for the Year Ended 31 December 2013
23rd Apr 20144:25 pmRNSTR-1: Notification of major interest in shares
14th Apr 201412:40 pmRNSResult of EGM
27th Mar 20147:00 amRNSProposed £10m Placing & Notice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.